| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21
|
Slovin, Susan F.
|
|
2005
|
23 |
24 |
p. 3114-3122
9 p.
|
artikel
|
| 2 |
A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus
|
Zhou, Yi-Hua
|
|
2005
|
23 |
24 |
p. 3157-3165
9 p.
|
artikel
|
| 3 |
Development of a phage displayed disulfide-stabilized Fv fragment vaccine against Vibrio anguillarum
|
Xia, Yong-juan
|
|
2005
|
23 |
24 |
p. 3174-3180
7 p.
|
artikel
|
| 4 |
Editorial Board/Aims and Scope
|
|
|
2005
|
23 |
24 |
p. IFC-
1 p.
|
artikel
|
| 5 |
Effect of combining the larval antigens Ancylostoma secreted protein 2 (ASP-2) and metalloprotease 1 (MTP-1) in protecting hamsters against hookworm infection and disease caused by Ancylostoma ceylanicum
|
Mendez, Susana
|
|
2005
|
23 |
24 |
p. 3123-3130
8 p.
|
artikel
|
| 6 |
Evaluation of a monovalent companion animal periodontal disease vaccine in an experimental mouse periodontitis model
|
Hardham, John
|
|
2005
|
23 |
24 |
p. 3148-3156
9 p.
|
artikel
|
| 7 |
Evaluation of OPV efficacy is required for polio eradication in India
|
Paul, Yash
|
|
2005
|
23 |
24 |
p. 3097-3098
2 p.
|
artikel
|
| 8 |
Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus
|
Reed, Douglas S.
|
|
2005
|
23 |
24 |
p. 3139-3147
9 p.
|
artikel
|
| 9 |
Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain
|
Zhang, Chuan-hai
|
|
2005
|
23 |
24 |
p. 3196-3201
6 p.
|
artikel
|
| 10 |
Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys
|
Zhou, Jun
|
|
2005
|
23 |
24 |
p. 3202-3209
8 p.
|
artikel
|
| 11 |
Induction of Gag-specific T-cell responses by therapeutic immunization with a Gag-expressing Sendai virus vector in macaques chronically infected with simian-human immunodeficiency virus
|
Kato, Moriaki
|
|
2005
|
23 |
24 |
p. 3166-3173
8 p.
|
artikel
|
| 12 |
In ovo administration of CpG oligodeoxynucleotides and the recombinant microneme protein MIC2 protects against Eimeria infections
|
Dalloul, Rami A.
|
|
2005
|
23 |
24 |
p. 3108-3113
6 p.
|
artikel
|
| 13 |
Modified multiplex PCR for identification of Bacillus Calmette–Guérin substrain Tokyo among clinical isolates
|
Seki, Masaaki
|
|
2005
|
23 |
24 |
p. 3099-3102
4 p.
|
artikel
|
| 14 |
Mucosal vaccination with an attenuated maedi–visna virus clone
|
Pétursson, Gudmundur
|
|
2005
|
23 |
24 |
p. 3223-3228
6 p.
|
artikel
|
| 15 |
Negative attitude of highly educated parents and health care workers towards future vaccinations in the Dutch childhood vaccination program
|
Hak, E.
|
|
2005
|
23 |
24 |
p. 3103-3107
5 p.
|
artikel
|
| 16 |
Non-clinical safety evaluation of novel vaccines and adjuvants: new products, new strategies
|
Brennan, Frank R.
|
|
2005
|
23 |
24 |
p. 3210-3222
13 p.
|
artikel
|
| 17 |
Peptide induces CD4+CD25+ and IL-10+ T cells and protection in airway allergy models
|
Zuleger, Cindy L.
|
|
2005
|
23 |
24 |
p. 3181-3186
6 p.
|
artikel
|
| 18 |
Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria
|
Malkin, Elissa M.
|
|
2005
|
23 |
24 |
p. 3131-3138
8 p.
|
artikel
|
| 19 |
The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis
|
Sinha, Anushua
|
|
2005
|
23 |
24 |
p. 3187-3195
9 p.
|
artikel
|
Tijdschrift beschrijving